These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11013236)
21. Truncated Tau caused by intron retention is enriched in Alzheimer's disease cortex and exhibits altered biochemical properties. Ngian ZK; Tan YY; Choo CT; Lin WQ; Leow CY; Mah SJ; Lai MK; Chen CL; Ong CT Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2204179119. PubMed ID: 36067305 [TBL] [Abstract][Full Text] [Related]
22. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies. Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370 [TBL] [Abstract][Full Text] [Related]
23. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras. Hettasch JM; Peoples KA; Greenberg CS J Biol Chem; 1997 Oct; 272(40):25149-56. PubMed ID: 9312126 [TBL] [Abstract][Full Text] [Related]
25. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease. Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469 [TBL] [Abstract][Full Text] [Related]
26. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. Hyman BT; Elvhage TE; Reiter J Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042 [TBL] [Abstract][Full Text] [Related]
27. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity. de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696 [TBL] [Abstract][Full Text] [Related]
28. Single molecule profiling of tau gene expression in Alzheimer's disease. Conrad C; Zhu J; Conrad C; Schoenfeld D; Fang Z; Ingelsson M; Stamm S; Church G; Hyman BT J Neurochem; 2007 Nov; 103(3):1228-36. PubMed ID: 17727636 [TBL] [Abstract][Full Text] [Related]
29. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672 [TBL] [Abstract][Full Text] [Related]
30. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease. Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792 [TBL] [Abstract][Full Text] [Related]
31. Interaction between tissue transglutaminase and amyloid-beta: Protein-protein binding versus enzymatic crosslinking. Wilhelmus MMM; Jongenelen CA; Bol JGJM; Drukarch B Anal Biochem; 2020 Mar; 592():113578. PubMed ID: 31923381 [TBL] [Abstract][Full Text] [Related]
32. Novel isoforms of tau that lack the microtubule-binding domain. Luo MH; Tse SW; Memmott J; Andreadis A J Neurochem; 2004 Jul; 90(2):340-51. PubMed ID: 15228591 [TBL] [Abstract][Full Text] [Related]
33. Tissue transglutaminase overexpression in the brain potentiates calcium-induced hippocampal damage. Tucholski J; Roth KA; Johnson GV J Neurochem; 2006 Apr; 97(2):582-94. PubMed ID: 16539654 [TBL] [Abstract][Full Text] [Related]
34. Molecular evolution of tau protein: implications for Alzheimer's disease. Nelson PT; Stefansson K; Gulcher J; Saper CB J Neurochem; 1996 Oct; 67(4):1622-32. PubMed ID: 8858947 [TBL] [Abstract][Full Text] [Related]
35. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Lai TS; Hausladen A; Slaughter TF; Eu JP; Stamler JS; Greenberg CS Biochemistry; 2001 Apr; 40(16):4904-10. PubMed ID: 11305905 [TBL] [Abstract][Full Text] [Related]
36. In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease. Mah VH; Eskin TA; Kazee AM; Lapham L; Higgins GA Brain Res Mol Brain Res; 1992 Jan; 12(1-3):85-94. PubMed ID: 1312209 [TBL] [Abstract][Full Text] [Related]
37. Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3. Ruiz-Gabarre D; Vallés-Saiz L; Carnero-Espejo A; Ferrer I; Hernández F; Garcia-Escudero R; Ávila J; García-Escudero V EBioMedicine; 2024 Feb; 100():104953. PubMed ID: 38181704 [TBL] [Abstract][Full Text] [Related]
38. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426 [TBL] [Abstract][Full Text] [Related]
39. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA. Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665 [TBL] [Abstract][Full Text] [Related]
40. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models. Wilhelmus MM; de Jager M; Smit AB; van der Loo RJ; Drukarch B Sci Rep; 2016 Feb; 6():20569. PubMed ID: 26837469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]